(UroToday.com) The 2025 American Society of Clinical Oncology Genitourinary (ASCO GU) cancers symposium held in San Francisco, CA was host to the Poster Session A: Prostate Cancer. Dr. Moein Moradpour ...

The approval of ¹⁷⁷Lu-PSMA-617 for adult patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) previously treated with androgen receptor pathway inhibitors and ...

A paper inadvertently published on the website of an ASCO conference revealed good results for mevrometostat in treating ...

Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, ...

When prostate cancer metastasizes, spreads outside of the prostate itself, it typically affects the structures in its immediate vicinity. Structures near the prostate likely to be involved include ...

TUESDAY, Feb. 4, 2025 (HealthDay News) -- It’s tough for a man to know what to do following a diagnosis of prostate cancer.

Restaurant critic and journalist Giles Coren has become the latest well-known figure to announce his diagnosis of prostate cancer. It comes in the same week the form of cancer was revealed as the ...

Traditional approaches to prostate cancer screening involve blood tests, MRI, and biopsies. However, in addition to being uncomfortable, some of these procedures result in overdiagnosis of low-grade ...

Lupron Depot (leuprolide acetate) is a prescription drug used to treat advanced prostate cancer and other conditions. The drug is given as an injection into a muscle. The dosage you’re ...